Poster Presentation at SITC 2023

Details of the poster presentations are as follows:

Title:	Givastomig, a novel Claudin18.2/4-1BB bispecific antibody, exerts bystander tumor-killing and synergistic anti-tumor activity with therapeutics in 1L/2L treatment for gastric cancer
Poster #:	792
Presenter:	Dr. Xuejun Liu, I-Mab
Date/Time:	Saturday, November 4, 2023 9:00 a.m. – 8:30 p.m. Pacific Time (12:00 p.m. – 11:30 p.m. Eastern Time)
Full abstract:	https://jitc.bmj.com/content/11/Suppl_1/889

Title:	ABL503 (TJ-L14B), PD-L1×4-1BB bispecific antibody, reinvigorates exhausted tumor-infiltrating CD8+ T cells and synergizes with PD-1 blockade
Abstract ID:	845
Presenter:	Dr. Jaeho Jung, ABL Bio
Date/Time:	Friday, November 3, 2023 9:00 a.m. – 7:00 p.m. Pacific Time (12:00 p.m. – 10:00 p.m. Eastern Time)
Full abstract:	https://jitc.bmj.com/content/11/Suppl_1/944